HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,346 | -3.9% | 6,161 | +8.2% | 0.00% | – |
| Q2 2023 | $6,604 | +44.5% | 5,693 | +88.1% | 0.00% | – |
| Q1 2023 | $4,569 | -70.2% | 3,026 | -50.6% | 0.00% | -100.0% |
| Q4 2022 | $15,315 | -40.8% | 6,126 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $25,852 | +51.3% | 6,126 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,092 | -51.2% | 6,126 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $35,041 | -85.7% | 6,126 | -77.2% | 0.00% | -66.7% |
| Q4 2021 | $245,752 | -14.6% | 26,917 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $287,743 | -31.1% | 26,917 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $417,752 | -0.0% | 26,917 | +4.4% | 0.01% | 0.0% |
| Q1 2021 | $417,861 | -26.5% | 25,778 | -4.1% | 0.01% | -33.3% |
| Q4 2020 | $568,746 | +42.8% | 26,872 | 0.0% | 0.01% | +28.6% |
| Q3 2020 | $398,243 | +0.7% | 26,872 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $395,287 | +25.3% | 26,872 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $315,477 | -48.6% | 26,872 | +2.8% | 0.01% | -30.0% |
| Q4 2019 | $614,055 | +35.6% | 26,130 | +6.7% | 0.01% | +25.0% |
| Q3 2019 | $452,936 | +7.4% | 24,483 | +7.9% | 0.01% | +14.3% |
| Q2 2019 | $421,788 | -22.5% | 22,689 | +2.0% | 0.01% | -30.0% |
| Q1 2019 | $543,912 | -8.2% | 22,255 | -2.6% | 0.01% | -16.7% |
| Q4 2018 | $592,547 | -15.7% | 22,843 | +2.8% | 0.01% | -7.7% |
| Q3 2018 | $703,105 | -99.9% | 22,215 | +7.1% | 0.01% | 0.0% |
| Q2 2018 | $805,710,000 | +66.2% | 20,739 | +18.1% | 0.01% | +85.7% |
| Q1 2018 | $484,712,000 | +174886.3% | 17,562 | +14.7% | 0.01% | +75.0% |
| Q4 2017 | $277,000 | -45.7% | 15,305 | -51.6% | 0.00% | +33.3% |
| Q3 2017 | $510,000 | +16.4% | 31,601 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $438,000 | +3.3% | 31,601 | +11.9% | 0.00% | 0.0% |
| Q1 2017 | $424,000 | +24.3% | 28,247 | +8.6% | 0.00% | +50.0% |
| Q4 2016 | $341,000 | -23.9% | 26,014 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $448,000 | -4.7% | 26,014 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $470,000 | +19.3% | 26,014 | +25.4% | 0.00% | 0.0% |
| Q1 2016 | $394,000 | -28.9% | 20,746 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $554,000 | +9.5% | 20,746 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $506,000 | -5.1% | 20,746 | +21.2% | 0.00% | 0.0% |
| Q2 2015 | $533,000 | +130.7% | 17,116 | -25.3% | 0.00% | +100.0% |
| Q4 2014 | $231,000 | +20.9% | 22,917 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $191,000 | -32.3% | 22,917 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $282,000 | – | 22,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |